15 Followers on Owler

Serimmune

Serimmune is an immune intelligence company that provides human immunity mapping and antigen stimulation solutions for research applications. Read more

Noah Nasser's photo - CEO of Serimmune

CEO

Noah Nasser

CEO Approval Rating

73/100

Founded:

2014

Status:

PrivateIndependent Company

SERIMMUNE TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Immunai is seen as one of Serimmune's top competitors. Immunai's headquarters is in New York, New York, and was founded in 2018. Like Serimmune, Immunai also works within the Biotechnology industry. Immunai generates NaN% of Serimmune's revenue.

Adaptive Biotechnologies is one of Serimmune's top rivals. Adaptive Biotechnologies was founded in 2009, and its headquarters is in Seattle, Washington. Like Serimmune, Adaptive Biotechnologies also works within the Biotechnology field. Adaptive Biotechnologies has 593 more employees than Serimmune.

Recursion is Serimmune's #3 rival. Recursion is a Public company that was founded in null in Salt Lake City, Utah. Recursion competes in the Health Care Technology industry. Compared to Serimmune, Recursion has 187 more employees.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Kineta a competitor of Serimmune?

Serimmune Acquisitions

No recent acquisitions found related to Serimmune

Serimmune Funding History

Since Serimmune was founded in 2014, it has participated in 4 rounds of funding. In total Serimmune has raised $24.0M. Serimmune's last funding round was on Aug 2020 for a total of $12.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Aug 2020
$12M

Illumina Ventures

Debt
May 2019
$1.4M
-
Equity
Jun 2017
$8M
Equity
Dec 2016
$2.5M
-

Since Serimmune was founded in 2014, it has participated in 4 rounds of funding. In total Serimmune has raised $24.0M. Serimmune's last funding round was on Aug 2020 for a total of $12.0M

Serimmune Investments

No recent investments found related to Serimmune

Serimmune News

June 9, 2020MarketScreener

Partners with Serimmune to Identify SARS-CoV-2 Therapeutic Antibody Candidates

(marketscreener.com) SOUTH SAN FRANCISCO, Calif. and GOLETA, Calif., June 9, 2020 /PRNewswire/ -- Twi... See more »
June 9, 2020FIRSTWORD PHARMA

Twist Bioscience Partners with Serimmune to Identify SARS-CoV-2 Therapeutic Antibody Candidates

SOUTH SAN FRANCISCO, Calif. and GOLETA, Calif., June 9, 2020 /PRNewswire/ -- Twist Bioscience Corpora... See more »
January 12, 2020pipelinereview

Serimmune and Atreca, Inc. Establish Research Collaboration Agreement in Oncology

GOLETA, CA, USA I January 10, 2020 ISerimmune, a leader in understanding the functional antibody repe... See more »
June 10, 2019socalTECH

SerImmune Finds $1.4M In Ongoing Funding

Santa Barbara-based SerImmune, a company developing immune mapping technology, has raised $1.4M in ne... See more »
June 27, 2017Global University Venturing

Merck and Illumina map out $8m SerImmune round

Illumina Ventures has led a series A round for SerImmune, which will use the funding to enhance its i... See more »
June 22, 2017The Pharma Letter

SerImmune enters collaboration with Merck

California, USA-based SerImmune has entered into a research and development collaboration agreement w... See more »

Social Media

Serimmune Headquarters

150 Castilian Drive Suite 100

Goleta, California93117

805-451-5083

Driving Directions »

Trending Companies

Serimmune Summary

ABOUT

Overview

Serimmune is an immune intelligence company that provides human immunity mapping and antigen stimulation solutions for research applications. Serimmune was founded in 2014. Serimmune's headquarters is located in Goleta, California, USA 93117. It has r...

CEO

Serimmune's CEO, Noah Nasser, currently has an approval rating of 73%. Serimmune's primary competitors are Immunai, Adaptive Biotechnologies & Recursion.

Frequently Asked Questions about Serimmune

  1. When was Serimmune founded?

    Serimmune was founded in 2014
  2. Who is Serimmune's CEO?

    Serimmune's CEO is Noah Nasser
  3. How much revenue does Serimmune generate?

    Serimmune generates $2M in revenue
  4. How much funding does Serimmune have?

    Serimmune has historically raised $24M in funding
  1. Where is Serimmune's headquarters?

    Serimmune's headquarters is in Goleta California, USA
  2. How many employees does Serimmune have?

    Serimmune has 29 employees
  3. What sector does Serimmune operate in?

    Serimmune is in Biotechnology, Medical Research & Laboratories
  4. Who are Serimmune's competitors?

    Serimmune's top competitors are Immunai, Adaptive Biotechnologies, Recursion